Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 36
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase III DES vs TMX for Postmenopausal ER-Positive or ER-Unknown Metastatic Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
SEG-79BRE334
2.
Phase III Chemotherapy with ADR/CTX/CACP Followed by Orchiectomy or Hormone Therapy with DES for Chemotherapy Failures with Metastatic Prostatic Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
under 70
NCI-78-C-56
NCI-NMOB-814
Last Modified:
7/13/2007
3.
Phase III Pelvic Irradiation vs Pelvic and Para-aortic Irradiation for Stage A2/B/C Adenocarcinoma of the Prostate
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NCI
RTOG-7506
RTOG-75-06
4.
Phase III Randomized Adjuvant Chemotherapy with CTX/DES vs DES Alone Following Surgery or Radiotherapy for Stage A2/B/C Prostatic Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
SEG-GU-81330
5.
Phase III Randomized Comparison of DES/LEV vs DES Alone in Stage C/D Prostatic Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NCI-D82-012-793
ICC-81U4
6.
Phase III DES or Orchiectomy vs CTX/5-FU plus DES or Orchiectomy vs Estracyt for Stage D2 Prostate Cancer without Prior Endocrine Therapy or Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NPCTG-1300
7.
Phase III Orchiectomy or DES with or without CTX/5-FU for Stable Stage D Cancer of the Prostate
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NPCTG-1400
8.
Phase III MEG vs MEG/DES vs Stilphostrol vs STZ for Previously Irradiated Hormone-Refractory Metastatic Prostatic Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
no age specified
NPCTG-1600
Last Modified:
12/1/1997
9.
Phase III Randomized Comparison of DES or Orchiectomy vs Buserelin vs DES/MTX or Orchiectomy/MTX in Newly Diagnosed Clinical Stage D2 Carcinoma of the Prostate with No Prior Chemotherapy or Hormonal Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
NPCTG-1700
Last Modified:
7/1/1997
10.
Phase III Combined vs Sequential ADR/CTX and Orchiectomy or DES for Stage D or Refractory Adenocarcinoma of the Prostate (Summary Last Modified 07/97)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
NCI
SWOG-8219
SWOG-8219
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute